CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cellsLang He, Hong Jiang, Shang Wang et al.|Translational Psychiatry|2021Cited by 48
Efficacy of cerebellar transcranial magnetic stimulation in spinocerebellar ataxia type 3: a randomized, single-blinded, controlled trialYuting Shi, Hong Jiang, Guangdong Zou et al.|Journal of Neurology|2023Cited by 21
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by <scp>SV2A</scp> Positron Emission TomographyZhao Chen, Hong Jiang, Guang Liao et al.|Movement Disorders|2023Cited by 21
New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3Linliu Peng, Hong Jiang, Zhao Chen et al.|Neurology|2021Cited by 19
Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine LearningLinliu Peng, Hong Jiang, Zhao Chen et al.|Movement Disorders|2020Cited by 18